Importance of CD4(+) T helper cell responses in tumor immunity.
about
Detection of HLA class II-dependent T helper antigen using antigen phage display.Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell responseOverlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survivalSimian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cellsDesensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma.Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculatureTransduction of an HLA-DP4-restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes.Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationIntratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy.Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer.Melatonin: a "Higgs boson" in human reproduction.Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion.Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma.Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma.The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses.T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy.CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand
P2860
Q31037295-8B50B2EE-6D68-4BB2-B30E-22E134D5FC7DQ31155155-54AC34F9-8D84-4AEC-AA88-B8FC68480781Q33406769-B846DEFD-E76E-4578-9D49-33FB624D4BB1Q33848587-BFA3F0AE-0F7E-4F09-9999-7D777CDDFBE3Q34382573-6A53F8A0-FA63-4DBC-B49B-D551CC78FCDFQ34415243-264B31EC-61D4-40F7-8591-AB6E444D250DQ34795354-7E076180-6480-4650-898D-DF371D82D845Q34991001-D0281F9D-AB5A-4EB9-92B9-87F95EAD07D0Q36402716-62ECB878-1D30-4980-9103-8927218B81CDQ37348411-CCCC1EF4-422A-4F9C-8C22-65221204BC85Q37564833-803081D7-A8B0-4B0C-8472-1BE2E88FFB0DQ38168904-60502DA8-31AA-49BD-9322-9878FDA2EE10Q38265922-B1248F6D-04A9-4620-9878-573C4C2EB40EQ38806235-CAF022F3-D762-4847-B4E6-0C2474E12BE9Q40230085-48975D31-461A-4AF5-BB6C-1AF19BDCF68EQ40596665-71E88618-79AD-4D62-8260-BF1BCB346319Q40749345-9217AF7D-B092-4A32-9C11-41ED37E325D6Q41757247-8332A185-6E15-40C7-8A12-583A1289D17AQ45086471-B4505DF5-FB6D-438E-B2AB-8A0DF1321144Q45901690-34CD39CD-67A1-4535-85FA-868F0863C177Q51979179-B4E20F98-01E3-47A5-913B-DA478828045BQ58535137-16219B87-8617-46BA-9B46-7372607082D9
P2860
Importance of CD4(+) T helper cell responses in tumor immunity.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Importance of CD4
@nl
Importance of CD4(+) T helper cell responses in tumor immunity.
@ast
Importance of CD4(+) T helper cell responses in tumor immunity.
@en
type
label
Importance of CD4
@nl
Importance of CD4(+) T helper cell responses in tumor immunity.
@ast
Importance of CD4(+) T helper cell responses in tumor immunity.
@en
prefLabel
Importance of CD4
@nl
Importance of CD4(+) T helper cell responses in tumor immunity.
@ast
Importance of CD4(+) T helper cell responses in tumor immunity.
@en
P2093
P1433
P1476
Importance of CD4(+) T helper cell responses in tumor immunity
@en
P2093
C J Melief
F Ossendorp
R Offringa
S H van der Burg
P356
10.1016/S0165-2478(00)00252-2
P50
P577
2000-09-01T00:00:00Z